New L.B. Bohle Technology Center Advances Development of Continuous Pharmaceutical Processing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New L.B. Bohle Technology Center Advances Development of Continuous Pharmaceutical Processing


L.B. Bohle is constructing a technology center next to its service center in Ennigerloh, Germany to provide additional space for developing, testing, and demonstrating continuous-production process equipment for the pharmaceutical industry, the company announced in a press release. Construction started this past August, and the center is expected to open in June 2014.

“Our customers are relying more and more on continuous production,” said company founder Lorenz Bohle, in the press release. “Our technology center will aid in the development of new products that improve the continuous production process because we will be able to visualize entire production lines in one plant using material from wet and dry granulation.”

At the technology center, L.B. Bohle processing experts will work with specialists from the Universities of Dusseldorf and Graz and experts from Siemens to develop new steps for the permanent and interprocess measuring, monitoring, and controlling of the continuous production process. L.B. Bohle will use these developments to produce new equipment and optimize current machinery for use in the pharmaceutical industry.

Source: L.B. Bohle

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here